1. Home
  2. UPLD vs CALC Comparison

UPLD vs CALC Comparison

Compare UPLD & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$0.70

Market Cap

17.3M

Sector

Technology

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.64

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
CALC
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
9.7M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
UPLD
CALC
Price
$0.70
$0.64
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$3.75
$10.00
AVG Volume (30 Days)
351.0K
114.1K
Earning Date
05-01-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
N/A
EPS
N/A
0.30
Revenue
$74,767,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.95
N/A
P/E Ratio
N/A
$2.10
Revenue Growth
6.95
N/A
52 Week Low
$0.50
$0.46
52 Week High
$3.90
$7.20

Technical Indicators

Market Signals
Indicator
UPLD
CALC
Relative Strength Index (RSI) 47.41 51.09
Support Level $0.68 $0.50
Resistance Level $0.74 $0.76
Average True Range (ATR) 0.11 0.06
MACD -0.01 0.01
Stochastic Oscillator 7.99 44.98

Price Performance

Historical Comparison
UPLD
CALC

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

Share on Social Networks: